N/A Completed N=41 Randomized Prevention

Use of High Flow Nasal Cannula During Sedation of Morbidly Obese Patients in the Endoscopy Suite

Morbid Obesity · Noninvasive Ventilation · Deep Sedation

Source: ClinicalTrials.gov NCT02859597 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Apr 2020

Primary outcomePrimary: Ability to Maintain Oxygenation — 0.55; 0.61 manipulations

Summary

This study evaluates the ability of high flow nasal cannula versus nasal cannula to oxygenate morbidly obese patients undergoing moderate to deep sedation for gastrointestinal procedures.

Outcome Measures

Outcome	Result	p-value
PRIMARY Ability to Maintain Oxygenation	0.55; 0.61	—
SECONDARY Number of Participants Requiring Airway Adjuncts During Procedure	0; 0	—
SECONDARY Number of Participants Who Need an Increase in Fraction of Inspired Oxygen	6; 3	—

Eligibility Criteria

Inclusion Criteria

Body Mass Index greater than or equal to 40
Scheduled for a gastrointestinal endoscopy that requires MAC sedation

Exclusion Criteria

Body Mass Index less than 40
Pregnant
Require either invasive or non-invasive ventilation for respiratory failure
Use home oxygen
Ventilation is via a tracheostomy
The procedure is emergent

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02859597). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.